The global prostate cancer nuclear medicine diagnostics market is expected to grow from US$ 720.12 million in 2022 to US$ 1,315.66 million by 2028. It is estimated to grow at a CAGR of 10.6% from 2022 to 2028.
The Global prostate cancer nuclear medicine diagnostics market was recently published by Thinking Caps Research & Consultancy, which includes the growth rate, analysis by product...